" class="no-js "lang="en-US"> Sonrava Health - Medtech Alert
Monday, September 15, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Sonrava Health | PTF

Sonrava Health

About Sonrava Health

Sonrava Health

Sonrava Health is a national family of health and wellness companies – including differentiated dental office brands with 582 affiliated offices, dental and vision benefit plans, provider networks, and consumer products and services – focused on quality, value and innovation and built on a platform of unique and efficient technology.

Related Story

Industry News

 Sonrava Health Enters Strategic Alliance with FCL Holdco

Sonrava Health Enters Strategic Alliance with FCL Dental, Owner of One of the Nation’s Largest Independent Dental Benefits Companies

December 1 2022

Sonrava Health has announced that it has entered into a strategic alliance with FCL Dental, […]